37% of New Drugs Approved by FDA in 2014 were for Treatment of Rare...
New data from the FDA (here) shows that 2014 was a banner year for orphan drugs, which are drugs that treat "rare" diseases/disorders affecting fewer than 200,000 people in the U.S.
The...
Back to the Future of Mobile Health Apps with Professor SYRUM’s Nephew
There is no more cherished and insulting image of a scientist/researcher than the "mad scientist" persona often depicted in cartoons.
A case in point is "Professor SYRUM" from Boehringer's EU-only Facebook game...
Is IMS Health’s Mobile Health App “Certification” Program Doomed to #FAIL?
"Welcome to the wild, wild, west of mobile health apps," says the voice over of an IMS Health animated Youtube video (embedded at the end of this post) that promotes two...
La Maladie du Grand Print Out: A Condition Abetted by Pharma Marketing & “Patient...
"Of course I was familiar, from my own practice, with the phenomenon of patients making lists, but I'd never known it had a name," says Suzanne Koven, M.D. in a NEJM...
Galderma and PMCPA Tangle in a Toxic Tussle
Galderma and PMCPA Tangle in a Toxic Tussle
Galderma tried to lay the blame on a rogue Key Account Manager (KAM), but PMCPA would have none of it. You won't believe what...
US Internet Users Don’t Need No Stinkin’ Mobile Apps!
Pharmaceutical companies have a lot of apps in the market, and have been making apps for a long time, but their apps aren’t seeing downloads and usage on par with the...
Pharma Mobile Ad Spend in 2014
I try to keep track of how money the U.S. pharmaceutical industry spends on digital advertising to see if there are any trends. Of particular interest to me these days is...
R&D Cost for Generics is Zero. Nothing. Nada. Nilch. So Why are Their Prices...
According to the latest estimate from Tufts economists, it now costs upwards of $2.6 billion to bring a new prescription drug to market (read "Cost to Bring a New Drug to...
Cost to Bring a New Drug to Market Is $2.6 Billion According to Tufts...
According to a new study by the Tufts Center for the Study of Drug Development (CSDD), which receives funding from the pharmaceutical industry, the estimated cost to develop a new Rx...
Imbuing Rx Drug Brands with Human Characteristics Boosts Sales
Rx Drug Personalities Perceived by Consumers
